Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Lassmann

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
NPJ Precision Oncology|August 14, 2024
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumorsJulia C Kuehn, Patrick Metzger, Nicolas Neidert, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
BMC Medicine|April 16, 2026
Detection rate and mutational landscape in extracranial arteriovenous malformations: a cohort studyVanessa F Schmidt, Denny Schanze, Richard Brill, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
NPJ Precision Oncology|October 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsMichael Menzel, Stephan Ossowski, Sebastian Kral, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
NPJ Precision Oncology|August 14, 2024
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumorsJulia C Kuehn, Patrick Metzger, Nicolas Neidert, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
BMC Medicine|April 16, 2026
Detection rate and mutational landscape in extracranial arteriovenous malformations: a cohort studyVanessa F Schmidt, Denny Schanze, Richard Brill, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
NPJ Precision Oncology|October 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsMichael Menzel, Stephan Ossowski, Sebastian Kral, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 8